Press Releases June 4, 2026 09:00 AM

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

NEXGEL to present at Planet MicroCap Conference in Las Vegas, showcasing its medical and OTC hydrogel products

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
NXGL

NEXGEL, Inc., a NASDAQ-listed company specializing in medical and over-the-counter hydrogel products, announced that CEO Adam Levy will present at the Planet MicroCap Conference in Las Vegas on June 16-18, 2026. The company highlights its longstanding expertise in electron-beam cross-linked hydrogels used in healthcare and consumer products and maintains strategic manufacturing partnerships.

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
NXGL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • NEXGEL CEO Adam Levy to present at Planet MicroCap Conference, increasing investor engagement.
  • Company specializes in ultra-gentle, high-water-content hydrogels for medical and OTC applications.
  • NEXGEL has well-established brands and strategic contract manufacturing relationships with major consumer healthcare companies.

LANGHORNE, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the Planet MicroCap Conference on June 16 – 18, 2026, in Las Vegas, NV.

Planet MicroCap Las Vegas 2026
Dates: June 16-18, 2026
Location: Bellagio Hotel & Casino, Las Vegas, NV
Booth: #517
Presentation Day and Time: Wednesday, June 17, 2026, at 1:30 P.M. PT
Presentation Location: Track 3 - Da Vinci 3
Webcast: https://ir.nexgel.com/news-events/events-presentations

To schedule a one-on-one investor meeting with Mr. Levy, please contact KCSA Strategic Communications at Nexgel@kcsa.com.

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@kcsa.com


Risks

  • Dependence on continued investor interest and ability to attract new capital at the conference.
  • Market competition in the healthcare and OTC product sectors which could affect growth.
  • Possible delays or challenges in contract manufacturing operations impacting revenue.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026